Demonstrates the potential of EDN and PTX3 as biomarkers for monitoring inflammation in pediatric asthma, suggesting complementary roles in clinical assessment.
EDN and PTX3 are associated with pediatric asthma, reflecting different components of airway inflammation. EDN demonstrated closer relationships with markers of disease activity suggesting its potential role as an adjunct biomarker for monitoring inflammation, while PTX3 primarily differentiated asthmatic from healthy children. These biomarkers should be considered complementary research tools rather than stand-alone diagnostic tests.
No takes yet. Share an insight, caveat, or question.
Abd-Elmawgood et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: